Alliance Pharma plc
APH
Delayed London Stock Exchange - 06/22 05:35:18 pm
97.6GBp
0%
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20172018
Sales103118
EBITDA26,832,0
Operating profit (EBIT)25,830,6
Pre-Tax Profit (EBT)-28,4
Net income28,922,0
EPS (GBp )6,034,60
Dividend per Share (GBp )1,331,43
Yield1,98%1,47%
Announcement Date03/27/2018
06:01am
-
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20172018
Debt72,356,4
Finance--
Operating income (EBITDA)26,832,0
Leverage
(Debt/EBITDA)
2,70x1,76x
Capital Expenditure2,241,75
Book Value Per Share (BVPS)--
Cash Flow per Share--
Announcement Date03/27/2018
06:01am
-
Financial Ratios
Size 2018e 2019e
Capitalization 457 M GBP -
Entreprise Value (EV) 513 M GBP 497 M GBP
Valuation 2018e 2019e
P/E ratio (Price / EPS) 21,2x 19,5x
Capitalization / Revenue 3,89x 3,65x
EV / Revenue 4,37x 3,98x
EV / EBITDA 16,1x 14,2x
Yield (DPS / Price) 1,47% 1,59%
Price to book (Price / BVPS) - -
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 26,0% 26,3%
operating Leverage (Delta EBIT / Delta Sales) 1,34x 1,14x
Net Margin (Net Profit / Revenue) 18,7% 19,1%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 9,90% 10,3%
Rate of Dividend 31,1% 31,1%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   1,49% 1,20%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 1,76x 1,15x
Price Earning Ratio
BNA & Dividende